Medical Nitrile Gloves Market Research Report- Forecast till 2027

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 16 2 MARKET INTRODUCTION 17 2.1 SCOPE OF THE STUDY 17 2.2 RESEARCH OBJECTIVE 17 2.3 MARKET STRUCTURE 17 2.4 ASSUMPTIONS & LIMITATIONS 18 3 RESEARCH METHODOLOGY 19 3.1 DATA MINING 19 3.2 SECONDARY RESEARCH 19 3.3 PRIMARY RESEARCH 20 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21 3.5 FORECASTING TECHNIQUES 22 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 23 3.6.1 BOTTOM-UP APPROACH 24 3.6.2 TOP-DOWN APPROACH 24 3.7 DATA TRIANGULATION 25 3.8 VALIDATION 25 4 MARKET DYNAMICS 26 4.1 OVERVIEW 26 4.2 DRIVERS 27 4.2.1 RISING INCIDENCES OF COVID-19 27 4.2.2 INCREASING DEMAND AND SHORTAGE OF MEDICAL NITRILE GLOVES 27 4.2.3 REFINED FEATURES AS COMPARED TO OTHER TYPES 28 4.3 RESTRAINTS 29 4.3.1 INCREASING COUNTERFEIT PRODUCTS & RISING PRICE 29 4.4 OPPORTUNITIES 30 4.4.1 NEW PRODUCT LAUNCH AND COLLABORATION FOR OPTIMIZATION OF PRODUCTION PROCESS 30 5 MARKET FACTOR ANALYSIS 31 5.1 VALUE CHAIN ANALYSIS 31 5.1.1 R&D 32 5.1.2 MANUFACTURING 32 5.1.3 DISTRIBUTION AND SALES 32 5.1.4 POST-SALES MONITORING 32 5.2 PORTER’S FIVE FORCES MODEL 32 5.2.1 BARGAINING POWER OF SUPPLIERS 33 5.2.2 BARGAINING POWER OF BUYERS 33 5.2.3 THREAT OF NEW ENTRANTS 34 5.2.4 THREAT OF SUBSTITUTES 34 5.2.5 INTENSITY OF RIVALRY 34 5.3 IMPACT ANALYSIS OF COVID-19 34 5.3.1 OVERVIEW 34 5.3.2 IMPACT ON PRICE, DEMAND & SUPPLY 35 6 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY TYPE 36 6.1 OVERVIEW 36 6.2 NON-POWDERED 37 6.3 POWDERED 37 7 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY USAGE 38 7.1 OVERVIEW 38 7.2 DISPOSABLE 39 7.3 REUSABLE 39 8 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY APPLICATION 40 8.1 OVERVIEW 40 8.2 EXAMINATION 41 8.3 SURGICAL 41 9 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY DISTRIBUTION CHANNEL 42 9.1 OVERVIEW 42 9.2 DIRECT SELLING 43 9.3 MEDICAL STORE 43 10 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY END USER 44 10.1 OVERVIEW 44 10.2 HOSPITALS & CLINICS 45 10.3 DIAGNOSTIC CENTERS 45 10.4 AMBULATORY SURGICAL CENTERS (ASCS) 46 10.5 REHABILITATION CENTERS 46 10.6 OTHERS 47 11 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY REGION 48 11.1 OVERVIEW 48 11.2 NORTH AMERICA 50 11.2.1 US 52 11.2.2 CANADA 54 11.3 EUROPE 56 11.3.1 GERMANY 58 11.3.2 UK 60 11.3.3 FRANCE 61 11.3.4 ITALY 62 11.3.5 SPAIN 64 11.3.6 REST OF EUROPE 65 11.4 ASIA PACIFIC 67 11.4.1 CHINA 69 11.4.2 JAPAN 71 11.4.3 INDIA 72 11.4.4 SOUTH KOREA 73 11.4.5 AUSTRALIA 75 11.4.6 REST OF ASIA PACIFIC 76 11.5 REST OF THE WORLD 78 11.5.1 MIDDLE EAST 80 11.5.2 AFRICA 81 11.5.3 LATIN AMERICA 83 12 COMPETITIVE LANDSCAPE 85 12.1 OVERVIEW 85 12.2 MAJOR PLAYERS IN THE GLOBAL MEDICAL NITRILE GLOVES MARKET 85 12.3 COMPETITIVE BENCHMARKING 86 12.4 COMPETITOR DASHBOARD 88 12.5 DEVELOPMENTS IN THE GLOBAL MEDICAL NITRILE GLOVES MARKET 89 12.5.1 ACQUISITION 89 12.5.2 PRODUCT LAUNCH/PRODUCT APPROVAL 89 12.5.3 EXPANSION 90 13 COMPANY PROFLE 91 13.1 DYNAREX CORPORATION 91 13.1.1 COMPANY OVERVIEW 91 13.1.2 FINANCIAL OVERVIEW 91 13.1.3 PRODUCTS/SERVICES OFFERED 91 13.1.4 KEY DEVELOPMENTS 91 13.1.5 SWOT ANALYSIS 92 13.1.6 KEY STRATEGIES 92 13.2 SHIELD SCIENTIFIC 93 13.2.1 COMPANY OVERVIEW 93 13.2.2 FINANCIAL OVERVIEW 93 13.2.3 PRODUCTS/SERVICES OFFERED 93 13.2.4 KEY DEVELOPMENTS 93 13.2.5 SWOT ANALYSIS 94 13.2.6 KEY STRATEGIES 94 13.3 MERCATOR MEDICAL S.A 95 13.3.1 COMPANY OVERVIEW 95 13.3.2 FINANCIAL OVERVIEW 95 13.3.3 PRODUCTS/SERVICES OFFERED 95 13.3.4 KEY DEVELOPMENTS 96 13.3.5 SWOT ANALYSIS 96 13.3.6 KEY STRATEGIES 96 13.4 HARTALEGA HOLDINGS BERHAD 97 13.4.1 COMPANY OVERVIEW 97 13.4.2 FINANCIAL OVERVIEW 97 13.4.3 PRODUCTS/SERVICES OFFERED 98 13.4.4 KEY DEVELOPMENTS 98 13.4.5 SWOT ANALYSIS 98 13.4.6 KEY STRATEGIES 99 13.5 SUPERMAX HEALTHCARE LTD 100 13.5.1 COMPANY OVERVIEW 100 13.5.2 FINANCIAL OVERVIEW 100 13.5.3 PRODUCTS/SERVICES OFFERED 100 13.5.4 KEY DEVELOPMENTS 101 13.5.5 SWOT ANALYSIS 101 13.5.6 KEY STRATEGIES 101 13.6 TOP GLOVE CORPORATION BHD 102 13.6.1 COMPANY OVERVIEW 102 13.6.2 FINANCIAL OVERVIEW 102 13.6.3 PRODUCTS/SERVICES OFFERED 103 13.6.4 KEY DEVELOPMENTS 103 13.6.5 SWOT ANALYSIS 104 13.6.6 KEY STRATEGIES 104 13.7 MCKESSON CORPORATION 105 13.7.1 COMPANY OVERVIEW 105 13.7.2 FINANCIAL OVERVIEW 105 13.7.3 PRODUCTS/SERVICES OFFERED 106 13.7.4 KEY DEVELOPMENTS 106 13.7.5 SWOT ANALYSIS 106 13.7.6 KEY STRATEGIES 107 13.8 ATRIUM MEDICAL CARE 108 13.8.1 COMPANY OVERVIEW 108 13.8.2 FINANCIAL OVERVIEW 108 13.8.3 PRODUCTS/SERVICES OFFERED 108 13.8.4 KEY DEVELOPMENTS 108 13.8.5 SWOT ANALYSIS 109 13.8.6 KEY STRATEGIES 109 13.9 KOSSAN RUBBER INDUSTRIES BHD 110 13.9.1 COMPANY OVERVIEW 110 13.9.2 FINANCIAL OVERVIEW 111 13.9.3 PRODUCTS/SERVICES OFFERED 111 13.9.4 KEY DEVELOPMENTS 112 13.9.5 SWOT ANALYSIS 112 13.9.6 KEY STRATEGIES 112 13.10 3M COMPANY 113 13.10.1 COMPANY OVERVIEW 113 13.10.2 FINANCIAL OVERVIEW 113 13.10.3 PRODUCTS OFFERED 114 13.10.4 KEY DEVELOPMENTS 114 13.10.5 SWOT ANALYSIS 114 13.10.6 KEY STRATEGIES 114 13.11 MEDLINE INDUSTRIES, INC. 115 13.11.1 COMPANY OVERVIEW 115 13.11.2 FINANCIAL OVERVIEW 115 13.11.3 PRODUCTS OFFERED 115 13.11.4 KEY DEVELOPMENTS 116 13.11.5 SWOT ANALYSIS 116 13.11.6 KEY STRATEGIES 116 13.12 ANSELL HEALTHCARE LLC 117 13.12.1 COMPANY OVERVIEW 117 13.12.2 FINANCIAL OVERVIEW 117 13.12.3 PRODUCTS OFFERED 118 13.12.4 KEY DEVELOPMENTS 118 13.12.5 SWOT ANALYSIS 119 13.12.6 KEY STRATEGIES 119 13.13 HONEYWELL INTERNATIONAL INC. 120 13.13.1 COMPANY OVERVIEW 120 13.13.2 FINANCIAL OVERVIEW 121 13.13.3 PRODUCTS/SERVICES OFFERED 121 13.13.4 KEY DEVELOPMENTS 121 13.13.5 SWOT ANALYSIS 122 13.13.6 KEY STRATEGIES 122 13.14 KIMBERLY-CLARK 123 13.14.1 COMPANY OVERVIEW 123 13.14.2 FINANCIAL OVERVIEW 123 13.14.3 PRODUCTS/SERVICES OFFERED 124 13.14.4 KEY DEVELOPMENTS 124 13.14.5 SWOT ANALYSIS 124 13.14.6 KEY STRATEGIES 124 14 APPENDIX 125 14.1 REFERENCES 125 14.2 RELATED REPORTS 125